About TREVENTIS CORPORATION
Treventis Corporation is a biotechnology company that utilizes a proprietary discovery engine called Common Conformational Morphology (CCM) to identify druggable active sites in misfolded protein targets, with applications in neurodegenerative diseases and oncology.
Proprietary CCM technology for identifying druggable active sites in misfolded proteinsIn silico modeling combined with in vitro, ex vivo, and in vivo model developmentDrug design for anti-misfolding small molecules in Alzheimer’s disease and other neurodegenerative conditionsU.S. DOD-funded research in oncology and neurodegenerative diseases
Is this your company?
Claim TREVENTIS CORPORATION to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim TREVENTIS CORPORATION & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.